DIN 02405016 — PERJETA 420 MG
PERJETA is a solution of Pertuzumab marketed by HOFFMANN-LA ROCHE LIMITED. The full Pertuzumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02405016
- Brand name
- PERJETA
- Active ingredient
- Pertuzumab
- Strength
- 420 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- HOFFMANN-LA ROCHE LIMITED
- Health Canada status
- MARKETED
- Drug class
- HER2-dimerization inhibitor (anti-HER2 monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.